Estrella Immunopharma Inc. Strategic Asset Allocation Index
Estrella Immunopharma Inc. strategic asset allocation index. Estrella Immunopharma Inc. (ESLA) has a Strategic Asset Allocation Index of 0.5% as of December 2022. Strategic assets (PP&E of $34.52K plus long-term investments of $-) total $34.52K, measured against net assets of $7.01 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Estrella Immunopharma Inc.'s balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Estrella Immunopharma Inc. Strategic Asset Allocation Index by Year (None–None)
Estrella Immunopharma Inc. strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Estrella Immunopharma Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ESLA company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|